Search for a report

GLOBAL INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

GLOBAL INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

Inkwood Research anticipates that the global infertility testing & treatment market will reach $35.59 billion by 2028, growing at a CAGR of 10.63% during the forecast period. The infertility testing & treatment market constitutes the tests and treatments for both genders to detect and treat infertility. Globally, cases associated with infertility are on the rise due to factors such as environment, changes in lifestyles, late marriages, and others. Moreover, numerous countries facing demographic shrinkages are highly keen on incentivizing the market.

GLOBAL INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

Global Infertility Testing & Treatment Market by Gender ( Male (Male Infertility Testing ( Dna Fragmentation, Oxidative Stress Analysis, Sperm Penetration Assay, Computer-assisted Semen Analysis (Casa), Sperm Agglutination, Microscopic Examination, Others ) Male Infertility Treatment (Medication, Assisted Reproductive Technology & Varicocele Surgery)) (Female ( Female Infertility Testing ( Ovulation Testing, Hysterosalpingography, Laparoscopy, Transvaginal Ultrasound, Ovarian Reserve Testing, Hormonal Level Testing, Others) Female Infertility Treatment ( IVF With ICSI, IUI, IVF Without ICSI, Surrogacy, Others)) Market by End-user ( Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) and by Geography.

Request free sample

Inkwood Research anticipates that the global infertility testing & treatment market will reach $35.59 billion by 2028, growing at a CAGR of 10.63% during the forecast period.

The infertility testing & treatment market constitutes the tests and treatments for both genders to detect and treat infertility. Globally, cases associated with infertility are on the rise due to factors such as environment, changes in lifestyles, late marriages, and others. Moreover, numerous countries facing demographic shrinkages are highly keen on incentivizing the market.

infertility-testing-and-treatment-market

Key market drivers propelling the global infertility testing & treatment market growth:

  • Rising stress and lifestyle disorders
  • Increased age of conception
    • Due to demanding careers, several couples marry and have kids late. This trend is highly prevalent in cities as well as urban areas.
    • A woman’s fertility reduces after 35, and male fertility begins to drop after the age of 40 to 45.
    • Couples also store their eggs and sperms in cryobanks for future family planning.
    • As a result, the increasing age of conception plays a vital role in driving the growth of the global market.
  • Increasing effectiveness of treatments
  • Growing government support

Key growth restraining factors:

  • High cost of testing and treatment
    • Infertility tests and treatments are costly and out of scope for many couples.
    • Although infertility treatments have high success rates, they often fail in some cases. Hence, these risks and higher costs further affect market adoption.
    • Moreover, several countries lack a well-established insurance sector that covers infertility treatments
  • Infertility considered a social taboo
  • Possible risks associated with infertility treatments

The report scope of the global infertility testing & treatment market covers the segmentation analysis of gender and end-user.

  • Male
    • Male Infertility Testing
      • DNA Fragmentation
        • DNA fragmentation held the highest market share in the male infertility testing segment in 2020.
        • The high level of DNA fragmentation in sperm cells is the leading cause of male infertility in 20% of the cases.
        • For healthy pregnancies, male partners should not have a high percentage of sperm with fragmented DNA.
        • The various methods for DNA fragmentation include acoustic shearing, nebulization forces, sonication, needle shearing, and enzyme-based treatments.
      • Oxidative Stress Analysis
      • Sperm Penetration Assay
      • Computer Assisted Semen Analysis (CASA)
      • Sperm Agglutination
      • Microscopic Examination
      • Others
    • Male Infertility Treatment
      • Medication
      • Assisted Reproductive Technology & Varicocele Surgery
  • Female
    • Female Infertility Testing
      • Ovulation Testing
      • Hormonal Level Testing
      • Hysterosalpingography
      • Laparoscopy
      • Transvaginal Ultrasound
      • Ovarian Reserve Testing
      • Others
    • Female Infertility Treatment
      • IVF with ICSI
      • IUI
      • IVF without ICSI
      • Surrogacy
      • Others

Geographically, the global infertility testing & treatment market has been segmented on the basis of four major regions, which includes:

  • North America: The United States and Canada
    • North America is set to be the dominating region by the end of the forecast period.
    • The key enablers for the market growth comprise factors such as the increased age of conception and improved effectiveness of fertility treatments.
    • Due to changing lifestyles, the age of conception in the United States and Canada is increasing. As individuals age, their fertility reduces, thereby necessitating fertility treatment.
    • Since fertility testing and treatments are quite costly, their success rates are significant. Over the past few years, owing to the advancements in technologies, the effectiveness of treatments has improved drastically. This aspect motivates couples to go through the process.
    • Furthermore, the rise in same-sex marriages is also expected to have a moderate impact on the growth of the market.
  • Europe: The United Kingdom, Germany, Russia, Belgium, Poland, Italy, France, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
  • Rest of World: Latin America, the Middle East & Africa

Major players operating in the global infertility testing & treatment market:

  • Fujifilm Irvine Scientific
  • EMD Group (Merck KGaA)
  • CooperSurgical
  • Cook Medical Inc
  • Vitrolife AB
  • Others

Key strategies adopted by some of these companies:

In May 2021, OBP Medical was acquired by CooperSurgical. In August 2020, Olympus Corporation acquired Arc Medical Design Limited. In November 2019, CooperSurgical launched the PGTai 2.0 technology platform.

Key trends of the global infertility testing & treatment market:

  • The market observes lucrative growth opportunities due to the adoption of technological advancements in time-lapse technology.
  • Advances in embryo biopsy and genetic screening play an essential role in fueling the global market’s growth.
  • The increasing demand for low-cost procedures serves as a key market trend.
  • Microscopic examination is the fastest-growing male infertility testing.

Frequently Asked Questions (FAQs):

  • What are the key opportunities within the global infertility testing & treatment market?

A: The growing nanotechnology industry, as well as Europe and China’s efforts to increase semiconductor manufacturing, are among the key opportunity avenues in the market.

  • Which gender captures the largest market share in the infertility testing and treatment market?

A: The female gender captures the largest market share in the infertility testing and treatment market.

  • Which is the leading country in the global infertility testing & treatment market?

A:  The United States is the leading country in the global infertility testing & treatment market.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • GROWING STRESS AND LIFESTYLE DISORDERS
      • INCREASED AGE OF CONCEPTION
      • INCREASING EFFECTIVENESS OF TREATMENTS
      • RISING GOVERNMENT SUPPORT
    • KEY RESTRAINTS
      • HIGH COST OF TESTING AND TREATMENT
      • INFERTILITY CONSIDERED A SOCIAL TABOO
      • POSSIBLE RISKS ASSOCIATED WITH INFERTILITY TREATMENTS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY BUYING CRITERIA
      • TREATMENT OPTIONS
      • QUALITY OF MEDICAL PROCEDURES
      • PRICE OF TREATMENTS
      • SHIFT TOWARDS MEDICAL TOURISM
      • REIMBURSEMENT
    • REGULATORY FRAMEWORK
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL PROCUREMENT
      • MANUFACTURING
      • SUPPLY LOGISTICS
      • DISTRIBUTION CHANNELS
      • END-USERS
  1. MARKET BY GENDER
    • MALE
      • MALE INFERTILITY TESTING
        • DNA FRAGMENTATION
        • OXIDATIVE STRESS ANALYSIS
        • SPERM PENETRATION ASSAY
        • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
        • SPERM AGGLUTINATION
        • MICROSCOPIC EXAMINATION
        • OTHERS
      • MALE INFERTILITY TREATMENT
        • MEDICATION
        • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
    • FEMALE
      • FEMALE INFERTILITY TESTING
        • OVULATION TESTING
        • HYSTEROSALPINGOGRAPHY
        • LAPAROSCOPY
        • TRANSVAGINAL ULTRASOUND
        • OVARIAN RESERVE TESTING
        • HORMONAL LEVEL TESTING
        • OTHERS
      • FEMALE INFERTILITY TREATMENT
        • IVF WITH ICSI
        • IUI
        • IVF WITHOUT ICSI
        • SURROGACY
        • OTHERS
  1. MARKET BY END-USER
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
    • COMPANY PROFILES
      • ADORFEM
      • BANGKOK IVF CENTER
      • COOK MEDICAL INC
      • COOPER SURGICAL
      • CREATE FERTILITY CENTRE
      • EMD GROUP (MERCK KGAA)
      • ENDO INTERNATIONAL PLC
      • ESCO MEDICAL
      • FERRING PHARMACEUTICALS
      • FERTILITY FIRST
      • FUJIFILM IRVINE SCIENTIFIC
      • GENEA LTD
      • HALOTECH DNA
      • HAMILTON THRONE LTD
      • IVFTECH
      • LABOTECT GMBH
      • OLYMPUS CORPORATION
      • PROGYNY
      • THERMO FISHER SCIENTIFIC INC
      • VITROLIFE AB

 

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – INFERTILITY TESTING & TREATMENT

TABLE 2: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 3: REGULATORY FRAMEWORK

TABLE 4: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL MALE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL MALE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL MALE INFERTILITY TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL MALE INFERTILITY TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: PROS AND CONS OF DNA SHARING METHODS

TABLE 15: GLOBAL DNA FRAGMENTATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 16: GLOBAL DNA FRAGMENTATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 17: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 18: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 19: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 20: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 21: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS (CASA) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 22: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS (CASA) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 23: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 24: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 25: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 26: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 27: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 28: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 29: GLOBAL MALE INFERTILITY TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 30: GLOBAL MALE INFERTILITY TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 31: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 32: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 33: GLOBAL MEDICATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 34: GLOBAL MEDICATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 35: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 36: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 37: GLOBAL FEMALE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 38: GLOBAL FEMALE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 39: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 40: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 41: GLOBAL FEMALE INFERTILITY TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 42: GLOBAL FEMALE INFERTILITY TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 43: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 44: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 45: COST OF OVULATION TESTING KITS IN THE US

TABLE 46: GLOBAL OVULATION TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: GLOBAL OVULATION TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: GLOBAL HYSTEROSALPINGOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 49: GLOBAL HYSTEROSALPINGOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 50: GLOBAL LAPAROSCOPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 51: GLOBAL LAPAROSCOPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 52: GLOBAL TRANSVAGINAL ULTRASOUND MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 53: GLOBAL TRANSVAGINAL ULTRASOUND MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 54: GLOBAL OVARIAN RESERVE TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 55: GLOBAL OVARIAN RESERVE TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 56: GLOBAL HORMONAL LEVEL TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 57: GLOBAL HORMONAL LEVEL TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 58: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 59: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 60: GLOBAL FEMALE INFERTILITY TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 61: GLOBAL FEMALE INFERTILITY TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 62: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 63: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 64: GLOBAL IVF WITH ICSI MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 65: GLOBAL IVF WITH ICSI MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 66: GLOBAL IUI MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 67: GLOBAL IUI MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 68: GLOBAL IVF WITHOUT ICSI MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 69: GLOBAL IVF WITHOUT ICSI MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 70: GLOBAL SURROGACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 71: GLOBAL SURROGACY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 72: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 73: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 74: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 75: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 76: GLOBAL FERTILITY AND SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 77: GLOBAL FERTILITY AND SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 78: GLOBAL HOSPITALS AND RESEARCH LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 79: GLOBAL HOSPITALS AND RESEARCH LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 80: GLOBAL CRYOBANKS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 81: GLOBAL CRYOBANKS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 82: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 83: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 84: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 85: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 86: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 87: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 88: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 89: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 90: REST OF WORLD INFERTILITY TESTING & TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 91: REST OF WORLD INFERTILITY TESTING & TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 92: LIST OF MERGERS & ACQUISITIONS

TABLE 93: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 94: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY BUYING CRITERIA

FIGURE 6: VALUE CHAIN ANALYSIS

FIGURE 7: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020

FIGURE 8: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020

FIGURE 10: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

FIGURE 12: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

FIGURE 13: CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 14: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

FIGURE 22: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020

FIGURE 26: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020

FIGURE 28: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

FIGURE 29: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

FIGURE 30: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

FIGURE 31: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

FIGURE 32: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 33: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

FIGURE 34: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 35: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 36: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020

FIGURE 37: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

FIGURE 38: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

FIGURE 39: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

FIGURE 40: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

FIGURE 41: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 42: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

FIGURE 43: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 44: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 45: GLOBAL INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

FIGURE 46: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 47: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: CANADA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: EUROPE INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 50: UNITED KINGDOM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: GERMANY INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: FRANCE INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 53: ITALY INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 54: RUSSIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 55: BELGIUM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 56: POLAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 57: REST OF EUROPE INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 58: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 59: CHINA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 60: JAPAN INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 61: INDIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 62: SOUTH KOREA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 63: INDONESIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 64: THAILAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 65: VIETNAM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 66: AUSTRALIA & NEW ZEALAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 67: REST OF ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION

FIGURE 68: REST OF WORLD INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 69: LATIN AMERICA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 70: MIDDLE EAST & AFRICA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY GENDER
    • MALE
      • MALE INFERTILITY TESTING
        • DNA FRAGMENTATION
        • OXIDATIVE STRESS ANALYSIS
        • SPERM PENETRATION ASSAY
        • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
        • SPERM AGGLUTINATION
        • MICROSCOPIC EXAMINATION
        • OTHERS
      • MALE INFERTILITY TREATMENT
        • MEDICATION
        • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
    • FEMALE
      • FEMALE INFERTILITY TESTING
        • OVULATION TESTING
        • HYSTEROSALPINGOGRAPHY
        • LAPAROSCOPY
        • TRANSVAGINAL ULTRASOUND
        • OVARIAN RESERVE TESTING
        • HORMONAL LEVEL TESTING
        • OTHERS
      • FEMALE INFERTILITY TREATMENT
        • IVF WITH ICSI
        • IUI
        • IVF WITHOUT ICSI
        • SURROGACY
        • OTHERS
  1. MARKET BY END-USER
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now